Premature clinical trials at UCLA
1 research study open to eligible people
open to all eligible people
A comprehensive analysis of the impact of exogenous enteral DHA and ARA supplementation on lipid metabolism including the production of downstream derived mediators and how this impacts important biological pathways such as metabolism, inflammation, and organogenic factors.
Los Angeles, California and other locations
Our lead scientists for Premature research studies include Kara Calkins, MD.